Titre : HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
link : HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
In Case You Missed ItSnapShots – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
Alan Franciscus
Did you know that people who were treated with direct-acting antiviral (DAA) medications….
- Were significantly less likely to die than the people who were untreated.
- Had at least a 20% decrease in liver fibrosis after 24-weeks of the completion of DAA therapy
- Experienced a 71% reduction in liver cancer risk after being cured with a DAA medication.
Continue reading........
Thus articles HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer
that is all articles HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer This time, hopefully can provide benefits to you all. Okay, see you in another article post.
You are now reading the article HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer the link address https://newsaninpiration.blogspot.com/2017/11/hcv-advocate-direct-acting-antiviral.html
Related Posts :
Life list- Raqqa may have fallen, but Syrian humanitarian group still fears instability
- Close to 3 million people access hepatitis C cure
- MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag
- MSF Issue Brief: Not even close - Reasons underlying the continued lack of access to HCV treatment are discussed
0 Response to "HCV Advocate – Direct-Acting Antiviral Treatment & Decrease a Incidence of Liver Cancer"
Post a Comment